APOTEEK LEFEVER-FEYAERTS
ActiveSummary
APOTEEK LEFEVER-FEYAERTS has been active since 1997 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €283k and a net result of €7k. Equity is growing by ~3.5% per year across the filed fiscal years. Its solvency ranks better than 95% of 4157 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
75
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability43▲+9
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21k at 30 days acceptable
short-term debt: 0.1% and cash: 9.8% of total assets, and 0.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
99.9%
Return on assets
2.4%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
15 d early
2024
8 d early
2023
1 d early
2022
20 d early
2021
3 d early
2020
1 d early
2019
1 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, full schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€7k
2024 · €-4k
2018: €10k
2019: €-7k
2020: €-24k
2021: €50k
2022: €43k
2023: €-14k
2024: €-4k
2018 → 2025
Working capital
€283k▲ 2.5%
2024 · €277k
2018: €212k
2019: €212k
2020: €197k
2021: €249k
2022: €292k
2023: €284k
2024: €277k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€252k-€295k▲ 17.0%€280k▼ 4.8%€277k▼ 1.4%€283k▲ 2.5%
Operating result€59k-€56k▼ 3.9%€-16k€-12k▲ 26.2%€-3k▲ 73.6%
Net result€50k-€43k▼ 13.6%€-14k€-4k▲ 72.4%€7k
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €3k in 2025 against €12k in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €284k
Equity
€283k ▲ 2.5%
Debt
€316 ▼ 77.8%
Debt's share of the balance-sheet total falls from 0.5% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
Debt to equity
0.00▼
2024 · 0.01
ROE
2.4%▲
2024 · -1.4%
ROA
2.4%▲
2024 · -1.4%
Debt ≤ 1 year
€316▼
2024 · €1k
Income taxes
€0▼
2024 · €78
A ratio outside any meaningful range has been withheld (balance sheet total €284k, equity €283k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 45 lines
Balance sheet
Code20242025
Assets
Total assets20/58€278k€284k▲
Current assets29/58€278k€284k▲
Stocks and contracts in progress3€0-
Stocks30/36€0-
Amounts receivable within one year40/41€247k€256k▲
Trade receivables40€0-
Other amounts receivable41€247k€256k▲
Cash at bank and in hand54/58€31k€28k▼
Deferred charges and accrued income490/1€221€20▼
Equity and liabilities
Total equity and liabilities10/49€278k€284k▲
Equity10/15€277k€283k▲
Contributions10/11€62k€62k=
Capital10€62k€62k=
Issued capital100€62k€62k=
Reserves13€215k€221k▲
Non-distributable reserves130/1€6k€6k=
Legal reserve130€6k€6k=
Distributable reserves133€208k€215k▲
Profit (loss) carried forward14€0-
Amounts payable17/49€1k€316▼
Amounts payable within one year42/48€1k€316▼
Trade debts44€1k€316▼
Suppliers440/4€1k€316▼
Taxes, remuneration and social security45€0-
Taxes450/3€0-
Remuneration and social security454/9€0-
Accrued charges and deferred income492/3€0-
Income statement
Code20242025
Remuneration, social security and pensions62€0-
Other operating charges640/8€399€400▲
Gross operating margin9900€-11k€-3k▲
Operating profit (loss)9901€-12k€-3k▲
Financial income75/76B€8k€10k▲
Recurring financial income75€8k€10k▲
Financial charges65/66B€122€132▲
Recurring financial charges65€122€132▲
Profit (loss) for the period before taxes9903€-4k€7k▲
Income taxes67/77€78€0▼
Profit (loss) for the period9904€-4k€7k▲
Profit (loss) for the period to be appropriated9905€-4k€7k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-18k€7k▲
Profit (loss) brought forward from the previous period14P€-14k€0▲
Transfer from equity791/2€18k€0▼
Transfer to equity691/2-€7k
To other reserves6921-€7k
Social balance
Average headcount (FTE)90870.0-
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
16-07
NBB filing
Annual accounts filed
fiscal year 2025 · full schema
2025
31-12
Financial
Back to profitnet €7k
Net result €7k after 2 loss-making years.
31-12
Financial
Liquidity times 5current ratio 897.59
Current ratio from 195.31 to 897.59; short-term debt falls from €1k to €316.
23-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Liquidity times 30current ratio 195.31
Current ratio from 6.43 to 195.31; short-term debt falls from €52k to €1k.
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
11-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
28-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Back to profitnet €50k
Net result €50k after 2 loss-making years.
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €-24k
Net result drops to €-24k, the lowest in the series; recovery starts the following year.
30-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
Show earlier events
2019
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
30-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Overijse · 1 establishment unit since 1997
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Brusselsesteenweg 2253090 OverijseGround area
889 m²
Building footprint
167 m²
Volume, LiDAR
916 m³
Parcel 23544D0137/00P003, Flanders · tallest building 8.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
APOTEEK LEFEVER-FEYAERTS
since 19972.084.644.618
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23544D0137/00P003 | Flanders | 889 m² | 1 · 167 m² | 8.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 2,000 EUR awarded · 2,000 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 2,000 EUR | 2,000 EUR |
Schemes
Hinderpremie bij openbare werken
Similar companies · same sector, comparable size
APOTHEEK KIRSTEN TUYTELEERS
BE 0403.675.792
Hemiksem · Eq €282,870
APOTHEEK BOUAKKA
BE 0837.524.724
Antwerpen · Eq €282,809
Apotheek Vandamme
BE 0878.445.559
Roeselare · Eq €282,786
WEST PHARMA
BE 0629.726.275
Anderlecht · Eq €284,177
APOTHEEK TOMBAL
BE 0848.202.939
Lier · Eq €282,352
Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,513 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPublic limited company
Founded30-05-1997
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 29 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.